Zevra Therapeutics to Present at the Piper Sandler 38th Annual Healthcare Conference
Zevra Therapeutics announced that its executive leadership team will present at the Piper Sandler 38th Annual Healthcare Conference in New York on December 2, 2026.
Stocks · News reference
Zevra Therapeutics announced its financial results for the third quarter ended September 30, 2026, reporting $37.8 million in net revenue.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Zevra Therapeutics announced that its executive leadership team will present at the Piper Sandler 38th Annual Healthcare Conference in New York on December 2, 2026.
Analysts have revised the price target for Zevra Therapeutics, Inc. to $18.00 per share from a previous target of $23.00.
U.S. stocks fell, but H World Group surged 9.3% on strong Q3 results and raised guidance; several other stocks posted notable gains.
Filed: 2026-11-03 AccNo: 0001434647-26-000085 Size: 321 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits